eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0005684|bladder cancer |
| Sentences | 3 |
| PubMedID- 22364733 | Background: gemcitabine plus cisplatinum was shown to exert comparable activity and a different toxicity profile when compared to the methotrexate, vinblastine, doxorubicin, cisplatinum (mvac) regimen in patients with advanced bladder cancer. |
| PubMedID- 19171491 | Sequential intravesical gemcitabine and mitomycin c chemotherapy regimen in patients with non-muscle invasive bladder cancer. |
| PubMedID- 23319449 | We conducted a comprehensive evaluation of reproductive factors and exogenous hormone use with a primary focus on menopausal hormone therapy use and risk of bladder cancer in women in the nih-aarp diet and health study. |
Page: 1